Australia's most trusted
source of pharma news
Thursday, 9 July 2026
Thursday, 9 July 2026
Subscribe
Login
GM tells why it was time to resign
In a heartfelt goodbye, Chiesi General Manager Melissa McGregor has opened up about the difficult and very personal decision to resign, describing it as her 'sliding doors' moment.
Lilly, patient group invest $680K
Eli Lilly Australia and a well-known patient group have joined forces to improve digital health solutions for complex care
TODAY
Butler fires a delisting warning shot
Minister sends a message loud and clear to both PBAC and two pharmas as public pressure mounts over feared PBS delisting
TODAY
Another GM gone, successor named
Yet another company has announced the departure of its General Manager, with a replacement already named
8 July
Extra leave coming to pharma?
Gen Z already makes up a third of the workforce and they already hold a crucial bargaining chip in workplace negotiations
8 July
Another drug leaving Australia
'Commercial changes' and 'commercial viability' given as the reasons behind this company's decision to cease supply
8 July
J&J to pull drug worldwide
The US pharma giant has confirmed the long-standing treatment will be removed from the Australian market this year
7 July
Latest Jobs
Distribution Clerk - WarehousingCommercial SpecialistLogistics PlannerLogistics and Customer Service SpecialistTrade Marketing ManagerCustomer Service RepresentativeClinical Trial InvestigatorSenior Medical Receptionist - 2IC38 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (24)
- Logistics and Customer Service Specialist - Belrose
- Customer Service Representative - Keysborough
- Customer Service Administrator - East Ryde
- Customer Service Representative - Warriewood
- Inside Sales Specialist - Sydney
- Inside Sales Specialist - Brisbane
- Customer Service Representative - Perth
- Inside Sales Specialist - Melbourne
- Customer Service Representative - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Auckland
- Customer Service Representative - Melbourne
- Customer Service Representative - Macquarie Park
- Territory Manager - Sydney
- Territory Manager - Sterilisation - Melbourne
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
Access & Reimbursement (1)
Clinical & Medical, R&D (6)
- Clinical Trial Investigator - Sutherland
- Senior Medical Receptionist - 2IC - Western Australia
- Clinical Trial Investigator - Melbourne
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
Regulatory, Pharmacovigilance & QA (4)
- Regulatory Affairs Manager - Belrose
- Senior Quality Assurance Associate - Randwick
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
Other (11)
- Distribution Clerk - Warehousing - Jacana
- Commercial Specialist - Brisbane
- Logistics Planner - North Ryde
- Warehouse Assistant - Eight Mile Plains
- Warehouse Assistant - Macquarie Park
- Pharmacy Assistant - Toongabbie
- Loan Kit Technician - Macquarie Park
- Finance Business Partner - North Ryde
- HR Consultant - Melbourne
- Senior SFE Analyst - Sydney
- Web Producer - Sydney
'Yes' with a price cut, patient cap
MSAC has supported public funding for a blood drug but with heavy conditions, just days after knocking back another new medicine
TODAY
Ex-Pfizer HQ verging on collapse
Support columns inside the company's former global headquarters in New York City have buckled, sparking immediate evacuations
TODAY
Red carpet win for cheeky campaign
A humorous ad for a serious disease has seen this company take home a prestigious award considered an 'Oscar' in industry
8 July
2 complete responses in 4 weeks
More astonishing success as trial logs two complete responses in a month for blood cancer patients that had previously failed therapy
8 July
Company lands its biggest buy ever
Shells out $14B to expand its therapeutic footprint and it's snagged a drug that's already exceeding sales forecasts
8 July
Revenue soars 25% after broad listing
Patients and prescribers have wasted no time embracing the broad listing of immunotherapies, with use jumping straight away
7 July
Novartis buys Aussie-backed firm
Pays more than $2 billion for an ADC biotech backed by Australian venture capital firm Brandon Capital
7 July
New FY brings fresh career start
The new financial year kicks off with a round of job moves including promotions, departures and retirements
7 July
Drug dropped from PBAC meeting
A new treatment will now be considered at a future PBAC meeting, with a pending TGA decision likely the reason
7 July
Who's been named GM... again?
Two years after stepping away from a GM role this executive is back at the top working for a new company
6 July
Blockbusters stuck in PBS limbo
Seven drugs recommended in March have been marked 'inactive' including two of the world's up-and-coming top-sellers
6 July
Gene genius: Aussies nab awards
Four Australian companies have picked up prizes at the Asia Pacific Cell & Gene Therapy Excellence Awards. Find out who
6 July
MSAC delivers a No over price
Blow after Committee dishes a rejection saying it was unable to discern if this drug 'was good value for money'
6 July
Novartis hit with first generic
The first copycat of Novartis' drug and a new high strength of Ozempic are among a long list of medicines approved
6 July Approvals Action